SCHEMBL9552156

SCHEMBL9552156

CCn1nc(CCS)nc1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 3/20 0.49
AGTR2 P50052 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9552057 0.92 AGTR1 (0.54) AGTR1AGTR2
SCHEMBL9552425 0.92 AGTR1 (0.53) AGTR1AGTR2
SCHEMBL9723555 0.92 AGTR1 (0.46) AGTR1AGTR2
SCHEMBL9552298 0.91 AGTR1 (0.62) AGTR1AGTR2
SCHEMBL9552184 0.90 AGTR1 (0.61) AGTR1AGTR2
SCHEMBL9552447 0.90 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9552098 0.90 AGTR1 (0.48) AGTR1AGTR2
SCHEMBL9552722 0.90 AGTR1 (0.44) AGTR1AGTR2
SCHEMBL9553718 0.90 AGTR1 (0.59) AGTR1AGTR2
SCHEMBL9552480 0.90 AGTR1 (0.45) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5229406-A Treatment of glaucoma G. D. SEARLE & CO. (US) 1993-07-20 US disclosed
US-5140036-A Hypotensive agents; congestive heart failure; angiotensin antagonists G. D. SEARLE & CO. (US) 1992-08-18 US disclosed
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO disclosed